- A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.
- Merck announced on September 3, 2025, that it is seeking potential approval for new drugs from the FDA.
Merck is seeking FDA approval for its drug Winrevair, based on data from the ZENITH, HYPERION, and Stellar studies.
6 reports, 2 independent
Updated Wed 00:00
No new developments lately
- Reports
- 6
- Developments
- 3
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Merck is seeking FDA approval for its drug Winrevair, based on data from the ZENITH, HYPERION, and Stellar studies.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Hyperion trial data provided for Merck drug, leading to FDA label update.1 source
- FDA granted priority review for Merck's drug application based on ZENITH trial data.
- Merck submitted Winrevair for FDA approval, supported by ZENITH, HYPERION, and Stellar study data.
Keep exploring
Part of
Merck announced on September 3, 2025, that it is seeking potential approval for new drugs from the FDA.Also in this story
- FDA granted Breakthrough Therapy designation for a drug developed by Merck.
- Ipsen received regulatory approval for Cabometyx, marking a competitive development with Merck in the renal cell carcinoma space.
- Iovance Biotherapeutics is evaluating its drug Amtagvi with Merck's Keytruda, potentially leading to FDA label expansion.
- Merck's product, Enflonsia, received approval from the FDA in the United States on August 28, 2025.
Within A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.
The entities involved
Related events
- Merck has set the list price for a drug that received approval from the FDA.
- Jazz Pharmaceuticals received FDA approval for a drug following positive clinical trial results.
- Teva's acquired product is currently undergoing review by the FDA.
- A study protocol involving a company based in Mont-Saint-Guibert was approved by the U.S. FDA.
- Moderna and Merck announced initial results from a late-stage trial for their novel cancer treatment.
Coverage
Newest first; wire copies grouped- dicardiology.com
- empr.com
- Unknown outlet
- Unknown outlet
- Unknown outlet